| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/01/2002 | CA2435410A1 Systemic formulations containing beta-carotene and derivatives thereof |
| 08/01/2002 | CA2434765A1 Degradation-resistant glucocorticosteroid formulations |
| 08/01/2002 | CA2434584A1 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
| 08/01/2002 | CA2434226A1 Process for preparing non-hygroscopic sodium valproate composition |
| 08/01/2002 | CA2434033A1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2433834A1 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | CA2433530A1 New film coating |
| 08/01/2002 | CA2428491A1 Orally ingestible baked radiopaque product for testing for dysphagia |
| 08/01/2002 | CA2428425A1 Method of treating hematologic tumors and cancers |
| 07/31/2002 | EP1226832A2 Preparation of further diagnostic agents |
| 07/31/2002 | EP1226831A1 Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts |
| 07/31/2002 | EP1226829A2 Stabilised liquid preparations of the protease or its proenzyme which activitate the blood coagulation factor VII |
| 07/31/2002 | EP1226825A1 Erection insufficiency remedies |
| 07/31/2002 | EP1226810A1 Use of a composition for entrapping oil and/or fat and the composition itself |
| 07/31/2002 | EP1226438A1 Composite nanospheres and their conjugates with biomolecules |
| 07/31/2002 | EP1226212A1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/31/2002 | EP1226154A1 Estradiol conjugates and uses thereof |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225956A1 Method and compositions for administering taxanes orally to human patients |
| 07/31/2002 | EP1225951A2 A dual adhesive transdermal drug delivery system |
| 07/31/2002 | EP1225929A2 A polymer micelle as monolayer or layer-laminated surface |
| 07/31/2002 | EP1225923A1 Method of inactivating pathogens |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225920A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 07/31/2002 | EP1225918A2 Conjugates useful in the treatment of prostate cancer |
| 07/31/2002 | EP1225917A2 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/31/2002 | EP1225916A1 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing |
| 07/31/2002 | EP1225902A1 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225898A2 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 07/31/2002 | EP1225897A2 Composition for treatment of constipation and irritable bowel syndrome |
| 07/31/2002 | EP1225888A2 Sustained-release formulations for treating cns-mediated disorders |
| 07/31/2002 | EP1225887A2 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP1225884A1 Method for administering a phosphodiesterase 4 inhibitor |
| 07/31/2002 | EP1225875A2 Apparatus and process for preparing crystalline particles |
| 07/31/2002 | EP1225874A1 Antiviral compositions |
| 07/31/2002 | EP1225873A2 Amphiphilic polymeric vesicles |
| 07/31/2002 | EP1225872A1 New and improved formulation for paclitaxel |
| 07/31/2002 | EP1225871A2 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 07/31/2002 | EP1225813A1 Cholesterol reducing stanol compositions, preparation and method of use |
| 07/31/2002 | EP1225812A2 Cholesterol reducing sterol compositions, preparation and method of use |
| 07/31/2002 | EP1225809A2 Methods for stabilizing liquid nutritional products and products so stabilized |
| 07/31/2002 | EP1158964A4 Edible coating composition |
| 07/31/2002 | EP0858325B1 Stable freeze-dried pharmaceutical formulation |
| 07/31/2002 | EP0825848B1 Translucent collagen formulations |
| 07/31/2002 | EP0810883B1 Conjugate comprising dtpa and albumin for individual medicament dosing |
| 07/31/2002 | EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 07/31/2002 | EP0799047B1 Viscous liquid conditioning topical germicides |
| 07/31/2002 | EP0760650B1 Antimicrobial oil-in-water emulsions |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | CN1361806A Pullulan film compositions |
| 07/31/2002 | CN1361789A Rapid dehydration of proteins |
| 07/31/2002 | CN1361785A Titanium derived compounds, preparation and use thereof |
| 07/31/2002 | CN1361689A Stable xylometazoline and oxymetazoline solution |
| 07/31/2002 | CN1361686A Percutaneously absorbable preparations |
| 07/31/2002 | CN1361685A Sustained release compositions, process for producing the same and use thereof |
| 07/31/2002 | CN1361684A Biodegradable poly (alkylene oxide)-poly cp-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/31/2002 | CN1361683A Novel preparation and administration form comprising an acid-labile active compound |
| 07/31/2002 | CN1361682A A liposome composition having resistance to freeze/thaw damage |
| 07/31/2002 | CN1361681A Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/31/2002 | CN1361677A Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/31/2002 | CN1088380C Injection capable of raising immunity of fowl and livestock and making their meats, egges and milks into health-care products |
| 07/31/2002 | CN1088362C Method of administering azithromycin |
| 07/30/2002 | US6426367 Methods for selectively occluding blood supplies to neoplasias |
| 07/30/2002 | US6426335 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 07/30/2002 | US6426332 Osteogenic protein is provided alone or dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces |
| 07/30/2002 | US6426218 Polypeptides; induction vascularization |
| 07/30/2002 | US6426208 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 07/30/2002 | US6426201 Mixing cereal with water; freezing |
| 07/30/2002 | US6426108 Chlorination ketone using sulfuryl chloride; esterification; hydrolysis |
| 07/30/2002 | US6426091 Sustained-release theophylline tablet |
| 07/30/2002 | US6426088 Sustained release; in situ insertion |
| 07/30/2002 | US6426087 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | US6426069 Method and compositions for increasing intestinal absorption of fats |
| 07/30/2002 | CA2268433C Improved interferon polymer conjugates |
| 07/30/2002 | CA2209714C A controlled release formulation for poorly soluble basic drugs |
| 07/30/2002 | CA2062428C Low dose dry pharmaceutical preparations |
| 07/30/2002 | CA2042529C Polysaccharide article and uses therefor |
| 07/30/2002 | CA2039052C Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions |
| 07/25/2002 | WO2002057424A2 Nucleic acid delivery formulations |
| 07/25/2002 | WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | WO2002057413A2 Peptides for activation and inhibition of delta pkc |
| 07/25/2002 | WO2002057316A1 Novel monoclonal antibody |
| 07/25/2002 | WO2002057260A1 Compounds for use in the treatment of skin conditions |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002057011A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method |
| 07/25/2002 | WO2002056918A2 Method of enhancing delivery of a therapeutic nucleic acid |
| 07/25/2002 | WO2002056916A2 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 07/25/2002 | WO2002056915A2 Complex of modafinil and cyclodextrin |
| 07/25/2002 | WO2002056914A1 Injections for endoscopy |
| 07/25/2002 | WO2002056913A2 Stabilized brivudine topical formulations containing metal oxide pigments |
| 07/25/2002 | WO2002056908A2 Artificial antigen-presenting cells |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056896A2 Treatment solution in addition to dressing material for caring for wounds |
| 07/25/2002 | WO2002056890A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |